New investors validate the enormous potential for VisionHealth and Kata®

Garching, July 15, 2019 – VisionHealth GmbH, a private company developing highly innovative, digital health solutions for respiratory indications, announces the closing of a growth financing round with Sanner Ventures and a highly experienced consortium of German investors led by Dr. Georg Matheis. The startup’s founder, previous investors and management participated as well. The investment will be used to drive development towards completion and promote Kata® for a rapid market entry. Kata® leverages AI to serve more than 250 Mio patients globally and make their respiratory therapy more efficient, by enhancing inhaler handling with a proprietary algorithm and therewith significantly increase the effectiveness of inhaled therapy.

Sanner Ventures, an arm of a German family-owned enterprise and competent supplier to pharma and medtec, states: “Our aim is to facilitate innovation for healthcare and well-being. We see high potential in VisionHealth to be a successful player in the rapidly growing global digital healthcare market.”

“Treatment and management of chronic respiratory diseases are a challenge, especially for aging societies.” adds Dr. Matheis, the consortium’s lead investor, physician and founder of several respiratory companies. “Drugs and treatment regime are established, but integrated patient care and sufficient handling training is lacking. VisionHealth is uniquely suited to bring that solution to patients globally. Therefore, I am very much looking forward to joining the dynamic and capable team.”

As part of the financing round Mr. Christian Schierholz from Sanner Ventures and Dr. Georg Matheis are now joining VisionHealth’s advisory board to strengthen the profound expertise of the startup. “The new investment round will enable us to further capitalize on our leadership position in the digital industry of respiratory medicines and as a highly attractive partner for all stakeholders involved in the care of patients using inhaled therapies.” stated Dr. Sabine Häußermann, CEO of VisionHealth GmbH.

About Sanner Ventures

As corporate venture capital office, Sanner Ventures aims to explore new business areas and to invest in early-stage technology companies in the area of health and well-being.
Sanner Ventures is devoted to products and solutions that help protect patient health and facilitate consumer engagement. For further information, please visit

About Dr. Georg Matheis

Dr. Georg Matheis is a successful physician and serial entrepreneur with more than 30 years of clinical and scientific experience. In his companies, he has translated several medical needs mainly for respiratory diseases into successful therapies.